The data displays the estimated market size for biomarkers in the U.S. from 2015 to 2024, by condition, measured in million USD. In 2015, the biomarker market in the United States was valued at around 9.3 billion USD in total, of which 3.6 billion dollars were in the area of oncology.
2015 | 900 | 1300 | 1100 | 2400 | 3600 |
2016 | 900 | 1500 | 1200 | 2900 | 3900 |
2017 | 1200 | 1500 | 1700 | 3000 | 4500 |
2018 | 1300 | 1700 | 1800 | 3500 | 5100 |
2019 | 1600 | 2000 | 2100 | 4000 | 5800 |
2020 | 1800 | 2300 | 2400 | 4600 | 6600 |
2021 | 2000 | 2700 | 2700 | 5400 | 7500 |
2022 | 2200 | 3000 | 3300 | 6200 | 8600 |
2023 | 2600 | 3500 | 3700 | 7100 | 9900 |
2024 | 3000 | 4100 | 4200 | 8200 | 11400 |